Terms: = Germ cell tumor AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Treatment
6925 results:
1. D-Loop Mutations as Prognostic Markers in Glioblastoma-A Pilot Study.
Szmyd B; Stanisławska P; Podstawka M; Zaczkowski K; Izbiński PM; Kulczycka-Wojdala D; Stawski R; Wiśniewski K; Janczar K; Braun M; Białasiewicz P; Jaskólski DJ; Bobeff EJ
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673919
[TBL] [Abstract] [Full Text] [Related]
2. Survival Outcome Prediction in Glioblastoma: Insights from MRI Radiomics.
Styliara EI; Astrakas LG; Alexiou G; Xydis VG; Zikou A; Kafritsas G; Voulgaris S; Argyropoulou MI
Curr Oncol; 2024 Apr; 31(4):2233-2243. PubMed ID: 38668068
[No Abstract] [Full Text] [Related]
3. Radiotherapy plus temozolomide with or without anlotinib in H3K27M-mutant diffuse midline glioma: A retrospective cohort study.
Liu C; Kuang S; Huang T; Wu J; Zhang L; Gong X
CNS Neurosci Ther; 2024 Apr; 30(4):e14730. PubMed ID: 38644565
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic significance of systemic inflammatory parameters in high-grade glial tumor patients: Two center experience.
Oztep Eskici S; Yilmaz EB
Medicine (Baltimore); 2024 Apr; 103(16):e37726. PubMed ID: 38640334
[TBL] [Abstract] [Full Text] [Related]
5. Risk factors for postoperative fever after laparoscopic adrenalectomy focusing on hormones produced: a case control study.
Izawa M; Takeda T; Anno T; Iwasawa T; Yasumizu Y; Tanaka N; Matsumoto K; Morita S; Kosaka T; Mizuno R; Asanuma H; Oya M
BMC Urol; 2024 Apr; 24(1):90. PubMed ID: 38637748
[TBL] [Abstract] [Full Text] [Related]
6. Laser interstitial thermal therapy for recurrent glioblastomas: a systematic review and meta-analysis.
Zhao X; Li R; Guo Y; Wan H; Zhou D
Neurosurg Rev; 2024 Apr; 47(1):159. PubMed ID: 38625588
[TBL] [Abstract] [Full Text] [Related]
7. Molecular patterns of resistance to immune checkpoint blockade in melanoma.
Lauss M; Phung B; Borch TH; Harbst K; Kaminska K; Ebbesson A; Hedenfalk I; Yuan J; Nielsen K; Ingvar C; Carneiro A; Isaksson K; Pietras K; Svane IM; Donia M; Jönsson G
Nat Commun; 2024 Apr; 15(1):3075. PubMed ID: 38594286
[TBL] [Abstract] [Full Text] [Related]
8. A nationwide phase II study of delayed local treatment for children with high-risk neuroblastoma: The Japan Children's Cancer Group Neuroblastoma Committee Trial JN-H-11.
Yoneda A; Shichino H; Hishiki T; Matsumoto K; Ohira M; Kamijo T; Kuroda T; Soejima T; Nakazawa A; Takimoto T; Yokota I; Teramukai S; Takahashi H; Fukushima T; Hara J; Kaneko M; Ikeda H; Tajiri T; Mugishima H; Nakagawara A
Pediatr Blood Cancer; 2024 Jun; 71(6):e30976. PubMed ID: 38577760
[TBL] [Abstract] [Full Text] [Related]
9. A Single-center Experience of Radiotherapy in Pediatric Ewing Sarcoma/Primitive Neuroectodermal tumor of the Chest Wall.
Yigit E; Gultekin M; Aydin B; Kutluk T; Yuce Sari S; Ekinci S; Orhan D; Yildiz F
J Pediatr Hematol Oncol; 2024 May; 46(4):197-205. PubMed ID: 38572993
[TBL] [Abstract] [Full Text] [Related]
10. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
[No Abstract] [Full Text] [Related]
11. [Value of surgery combined chemotherapy and radiation therapy in locally advanced neuroendocrine carcinoma of the cervix: a single-center retrospective cohort study].
Song XC; Zhang H; Zhong S; Tan XJ; Ma SQ; Jin Y; Pan LY; Wu M; Cao DY; Yang JX; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):200-209. PubMed ID: 38544449
[No Abstract] [Full Text] [Related]
12. Repurposed Drugs Celecoxib and Fmoc-L-Leucine Alone and in Combination as Temozolomide-Resistant Antiglioma Agents-Comparative Studies on Normal and Immortalized cell Lines, and on
Uram Ł; Pieńkowska N; Misiorek M; Szymaszek Ż; Twardowska M; Siorek M; Wołowiec S
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542198
[TBL] [Abstract] [Full Text] [Related]
13. Outcome of adjuvant immunotherapy in a real-world nation-wide cohort of patients with melanoma.
Holmstroem RB; Pedersen S; Jurlander R; Madsen K; Donia M; Ruhlmann CH; Schmidt H; Haslund CA; Bastholt L; Svane IM; Ellebaek E
Eur J Cancer; 2024 May; 202():114023. PubMed ID: 38518533
[TBL] [Abstract] [Full Text] [Related]
14. Prediction of disease recurrence in patients after complete pancreatic NET (PanNET) G2 resection.
Olearska H; Sowa-Staszczak A; Morawiec-Sławek K; Kurzyńska A; Kolasa M; Tkacz E; Szumińska M; Hubalewska-Dydejczyk A; Opalinska M
Endokrynol Pol; 2024; 75(1):102-108. PubMed ID: 38497396
[TBL] [Abstract] [Full Text] [Related]
15. The outcome in patients with BRAF-mutated metastatic melanoma treated with anti-programmed death receptor-1 monotherapy or targeted therapy in the real-world setting.
Kopecký J; Pásek M; Lakomý R; Melichar B; Mrazová I; Kubeček O; Arenbergerová M; Lemstrová R; Švancarová A; Tretera V; Hlodáková A; Žváčková K
Cancer Med; 2024 Mar; 13(5):e6982. PubMed ID: 38491825
[TBL] [Abstract] [Full Text] [Related]
16. Chemo-immunotherapy with dinutuximab beta in patients with relapsed/progressive high-risk neuroblastoma: does chemotherapy backbone matter?
Raiser P; Schleiermacher G; Gambart M; Dumont B; Defachelles AS; Thebaud E; Tandonnet J; Pasqualini C; Proust S; Entz-Werle N; Aerts I; Ndounga-Diakou LA; Petit A; Puiseux C; Khanfar C; Rouger J; Mansuy L; Benadiba J; Millot F; Pluchart C; Laghouati S; Geoerger B; Vassal G; Valteau-Couanet D; Berlanga P
Eur J Cancer; 2024 May; 202():114001. PubMed ID: 38489858
[TBL] [Abstract] [Full Text] [Related]
17. Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma.
Albrecht LJ; Dimitriou F; Grover P; Hassel JC; Erdmann M; Forschner A; Johnson DB; Váraljai R; Lodde G; Placke JM; Krefting F; Zaremba A; Ugurel S; Roesch A; Schulz C; Berking C; Pöttgen C; Menzies AM; Long GV; Dummer R; Livingstone E; Schadendorf D; Zimmer L
Eur J Cancer; 2024 May; 202():113976. PubMed ID: 38484692
[TBL] [Abstract] [Full Text] [Related]
18. Strabismus management in retinoblastoma survivors.
Masoomian B; Shields CL; Esfahani HR; Khalili A; Ghassemi F; Rishi P; Akbari MR; Khorrami-Nejad M
BMC Ophthalmol; 2024 Mar; 24(1):114. PubMed ID: 38481156
[TBL] [Abstract] [Full Text] [Related]
19. Regulation of cell Cycle Progression through RB Phosphorylation by Nilotinib and AT-9283 in Human Melanoma A375P cells.
Pham TM; Ahmed M; Lai TH; Bahar ME; Hwang JS; Maulidi RF; Ngo QN; Kim DR
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474202
[TBL] [Abstract] [Full Text] [Related]
20. Fibroblast Growth Factor Receptor Inhibitors Decrease Proliferation of Melanoma cell Lines and Their Activity Is Modulated by Vitamin D.
Piotrowska A; Nowak JI; Wierzbicka JM; Domżalski P; Górska-Arcisz M; Sądej R; Popiel D; Wieczorek M; Żmijewski MA
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473753
[TBL] [Abstract] [Full Text] [Related]
[Next]
